Company Summary
Search
Home Page
 
Acasti Pharma Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
February 29TradingN
Board of Directors
NamePosition
Harlan Waksal  Director of the Board
Henri Harland  President & CEO
  Director of the Board
  Corporate Secretary
Jean Claude Debard  Director of the Board
Reed V. Tuckson  Director of the Board
Ronald Denis  Chairperson of the Board
Valier Boivin  Director of the Board
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
1/Feb/2002  Canada Quebec  
Exchange Filing Office
Location
Montreal Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Research and Development in the Physical, Engineering and Life Sciences  (not available) 
Securities
SymbolSecurity NameMarketStatus
APOAcasti Pharma Inc.TSX VentureTRADING
Name HistoryFromTo
Acasti Pharma Inc.8/Nov/2010Present
Company Facts Reconciliation
SubjectDate Returned
Summer 2013 CFRNot Received
Associations
Auditing Firm:  KPMG LLP
Transfer Agent:  Computershare Investor Services Inc.
Latest Information
TypeDateTitle
News Releases  21/Feb/2014  NEWS RELEASE - PRIVATE PLACEMENT NON BROKERED[MARKET NEWS]
    NEWS RELEASE - ACASTI AND NEPTUNE PROVIDE UPDATE ON PATENT LITI[MARKET NEWS]
    NEWS RELEASE - CLOSING OF CAD$2.15 MILLION PRIVATE PLACEMENT[MARKET NEWS]
Bulletins  21/Feb/2014  PP-N-B
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data